secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001558370-23-018565
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health Q3 revenue $62.7M, up 121% YoY; Adj. EBITDA $1.3M; guides five new hospitals in 2024
--------------------------------------------------------------------------------

- Net loss attributable to Nutex Health $(5.5)M; Q3 2022 loss $(412.2)M included $398M goodwill impairment.
- Adjusted EBITDA of $1.3M; net cash from operating activities of $2.0M in Q3 2023.
- Expects to open five new micro-hospitals in 2024; raised $4.4M from $15M private offering through Nov. 6, 2023.
- Appointed Josh DeTillio as COO on Sept 5, 2023; acquired two Florida IPAs with 4,400 managed care patients.
- Cash and cash equivalents of $26.8M as of Sept 30, 2023; total assets $479.6M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000155837023018565/0001558370-23-018565-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000155837023018565/nutx-20231109x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-018565

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer